Article Data

  • Views 185
  • Dowloads 43

Original Research

Open Access

Fear of Covid-19 in patients with obesity and the influence on bariatric surgery rates

  • Mehmet Celal Kizilkaya1
  • Erkan Somuncu1

1University of Health Sciences, Kanuni Sultan Süleyman Training and Research Hospital, General Surgery, Istanbul, Turkey

DOI: 10.22514/sv.2020.16.0104 Vol.17,Issue 1,January 2021 pp.26-31

Published: 08 January 2021

*Corresponding Author(s): Mehmet Celal Kizilkaya E-mail: drmckizilkaya@gmail.com

Abstract

Introduction: In this study, we aimed to examine and compare the effect of fear of Covid-19 disease on the lives of obese individuals and the effect of this fear on bariatric surgery rates, and the state of fear and anxiety in operated individuals. Materials and Methods: A total of 568 eligible patients were recruited for the study. The patients were screened for age, sex, body mass index (BMI), having bariatric surgery history, comorbidities and Covid-19 symptoms and diagnosis. The patients were evaluated for fear of Covid-19 with the Fear of Covid-19 Scale (FCV-19S). Results: A total of 568 patients were included in this study. The mean age of the female patients was 49. 71 ± 12.35. The mean age of the male patients was 40.38 ± 9.38. Of the patients, 208 (36.6%) were male, while 360 (63.4%) were female. There were significantly more patients with a bariatric surgery history and at least one Covid-19 symptom were (39.3%) than patients with no bariatric surgery history (20.9%) (P < 0.05). Patients with a BMI lower than 50 kg/m2 had significantly higher FCV-19S scores (P < 0.05). Conclusion: The population with the highest BMI may show less fear of Covid-19, according to FCV-19S. This kind of behaviour (fear, anxiety, etc.) may be seen as an effect of disregard. Obese populations should be treated by psychiatrists and should be educated about obesity and Covid-19.

Keywords

Fear; Coronavirus; Covid-19; Bariatric surgery; Fear scale; Obesity

Cite and Share

Mehmet Celal Kizilkaya,Erkan Somuncu. Fear of Covid-19 in patients with obesity and the influence on bariatric surgery rates. Signa Vitae. 2021. 17(1);26-31.

References

[1] Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. Journal of the American Medical Association. 2020; 323: 1061-1069.

[2] Lin CY. Social reaction toward the 2019 novel coronavirus (Covid-19). Social Health and Behavior. 2020; 3: 1-2.

[3] Ahorsu DK, Lin CY, Imani V, Saffari M, Griffiths MD, Pakpour AH. The fear of Covid-19 scale: development and initial validation. International Journal of Mental Health and Addiction. 2020: 1-9.

[4] Dong L, Hu S, Gao J. Discovering drugs to treat coronavirus disease 2019 (Covid-19). Drug Discoveries & Therapeutics. 2020; 14: 58-60.

[5] Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, et al. Comorbidity and its impact on 1590 patients with Covid-19 in China: a nationwide analysis. European Respiratory Journal. 2020; 55: 2000547.

[6] Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020; 395: 497-506.

[7] Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 2020; 395: 507-513.

[8] Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. Journal of the American Medical Association. 2020; 323: 1061-1069.

[9] Liu K, Fang YY, Deng Y, Liu W, Wang MF, Ma JP, et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chinese Medical Journal. 2020; 133: 1025-1031.

[10] Xu XW, Wu XX, Jiang XG, Xu KJ, Ying LJ, Ma CL, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. British Medical Journal. 2020; 368: m606.

[11] Fang L, Gao P, Bao H, Tang X, Wang B, Feng Y, et al. Chronic obstructive pulmonary disease in China: a nationwide prevalence study. The Lancet Respiratory Medicine. 2018; 6: 421-430.

[12] Duncan LA, Schaller M, Park JH. Perceived vulnerability to disease: de-velopment and validation of a 15-item self-report instrument. Personality and Individual Differences. 2009; 47: 541-546.

[13] Pappas G, Kiriaze IJ, Giannakis P, Falagas ME. Psychosocial conse-quences of infectious diseases. Clinical Microbiology and Infection. 2009; 15: 743-747.

[14] Ropeik D. The consequences of fear. EMBO Reports. 2004; 5: S56-S60.

[15] Shiley KT, Nadolski G, Mickus T, Fishman NO, Lautenbach E. Differences in the epidemiological characteristics and clinical outcomes of pandemic (H1N1) 2009 influenza, compared with seasonal influenza. Infection Control & Hospital Epidemiology. 2010; 31: 676-682.

[16] Booth CM, Matukas LM, Tomlinson GA, Rachlis AR, Rose DB, Dwosh HA, et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. Journal of the American Medical Association. 2003; 289: 2801-2809.

[17] Garbati MA, Fagbo SF, Fang VJ, Skakni L, Joseph M, Wani TA, et al. A comparative study of clinical presentation and risk factors for adverse outcome in patients hospitalised with acute respiratory disease due to MERS coronavirus or other causes. PLoS One. 2016; 11: e0165978.

[18] Matsuyama R, Nishiura H, Kutsuna S, Hayakawa K, Ohmagari N. Clinical determinants of the severity of middle east respiratory syndrome (MERS): a systematic review and meta-analysis. BMC Public Health. 2016; 16: 1203.

[19] WHO. Clinical management of severe acute respiratory infection when novel coronavirus(nCoV) infection is suspected: interim guidance. 2020; Available at: https://www.who.int/internal-publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected.

[20] Mitchell NS, Catenacci VA, Wyatt HR, Hill JO. Obesity: overview of an epidemic. Psychiatric Clinics of North America. 2011; 34: 717-732.

[21] Cotter EW, Kelly NR. Stress-related eating, mindfulness, and obesity. Health Psychology. 2018; 37: 516-525.

[22] Rundle AG, Park Y, Herbstman JB, Kinsey EW, Wang YC. Covid-19-related school closings and risk of weight gain among children. Obesity (Silver Spring). 2020; 28: 1008-1009.

[23] Palaiodimos L, Kokkinidis DG, Li W, Karamanis D, Ognibene J, Arora S, et al. Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with Covid-19 in the Bronx, New York. Metabolism. 2020; 108: 154262.

[24] Chiappetta S, Sharma AM, Bottino V, Stier C. Covid-19 and the role of chronic inflammation in patients with obesity. International Journal of Obesity(London). 2020: 44:1790-1792.

[25] Cai Q, Chen F, Wang T, Luo F, Liu X, Wu Q, et al. Obesity and Covid-19 severity in a designated hospital in Shenzhen, China. Diabetes Care. 2020: 43: 1392-1398.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.

IndexCopernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.

Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.

Scopus Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.

Submission Turnaround Time

Conferences

    Top